Ventas Stock News

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) will issue its first quarter 2022 earnings release after the close of trading on the New York Stock Exchange on T

Proxy advisory firms Glass Lewis and Institutional Shareholders Services urged investors in healthcare real estate trust Ventas Inc to back management's director candidates and reject activist investm

Our 3 Worst Performing Investments

Ventas' investment in a Canadian senior-housing business has paid off handsomely during the industry downturn.

The Orion Office Conundrum

Ventas is focused on producing net operating income growth in its core division.

Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ: SBRA ) was changed from Underperform to Neutral. In the fourth quarter, Sabra Health Care REIT showed an EPS of $0.39, compared to $0.42 from the year-ago quarter. The current stock performance of Sabra Health Care REIT shows a 52-week-high of $19.02 and a 52-week-low of $12.31. Moreover, at the end of the last trading period, the closing price was at $13.87. CLSA upgraded the previous rating for Gaotu Techedu Inc (NYSE: GOTU ) from Sell to Underperform. For the fourth quarter, Gaotu Techedu had an EPS of $0.19, compared to year-ago quarter EPS of $0.39. The current stock performance of Gaotu Techedu shows a 52-week-high of $93.33 and a 52-week-low of $1.39. Moreover, at the end of the last trading period, the closing price was at $1.70. B of A Securities upgraded the previous rating for XPO Logistics Inc (NYSE: XPO ) from Neutral to Buy. In the fourth quarter, XPO Logistics showed an EPS of $1.34, compared to $1.19 from the year-ago quarter.

BMO analyst Juan Sanabria on Friday upgraded health care real estate investment trust Ventas (VTR) due to increased confidence in the senior housing recovery.The analyst is forecasting…

Within the last quarter, Ventas (NYSE: VTR ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 0 1 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Ventas has an average price target of $59.0 with a high of $62.00 and a low of $53.00. Below is a summary of how these 4 analysts rated Ventas over the past … Full story available on Benzinga.com

Land & Buildings Investment Management confirmed on Monday that it is nominating its founder and chief investment officer, Jonathan Litt, to Ventas''s <> board in an effort to…

Activist investor Land & Buildings is said to nominate founder Jonathan Litt to the board of senior housing REIT Ventas Inc

The real-estate focused investment firm owns roughly $50 million of the healthcare REIT’s shares.

The real-estate focused investment firm owns roughly $50 million of the healthcare REIT’s shares.

PARIS--(BUSINESS WIRE)--Regulatory News: Vitura (Paris:VTR): Jérôme Anselme, Chief Executive Officer of Vitura, commented: "Despite the ongoing global pandemic and uncertain environment, 2021 was a very active year for Vitura, with the acquisition of our second Parisian real estate asset, solid rental transactions and the success of our CSR strategy rewarded by the GRESB and marked by the signature of a €525 million green loan. Driven by the new Vitura identity, we are reimagining sustainable,